Principal component analysis of clinical characteristics of pulmonary sarcoidosis with or without extrapulmonary lesions: a single-center observational study in Japan

Principal component analysis of clinical characteristics of pulmonary sarcoidosis with or without extrapulmonary lesions: a single-center observational study in Japan

Authors

  • Yohei Maki Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College
  • Jun Miyata Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
  • Ryohei Suematsu Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College
  • Hisashi Sasaki Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College
  • Yoshifumi Kimizuka Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College
  • Yuji Fujikura Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College
  • Akihiko Kawana Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College

Keywords:

Bronchoalveolar lavage fluid, Eosinophils, Neutrophils, Principal component analysis, Sarcoidosis, Extrapulmonary sarcoidosis

References

Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26:527–34. doi: 10.1097/mcp.0000000000000715.

Li CW, Tao RJ, Zou DF, Li MH, Xu X, Cao WJ. Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China. BMJ Open. 2018;8:e018865. doi: 10.1136/bmjopen-2017-018865.

Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020; 201:e26-e51. doi: 10.1164/rccm.202002-0251ST.

Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020;11:1443. doi: 10.3389/fimmu.2020.01443.

Ziegenhagen MW, Rothe ME, Schlaak M, Müller-Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J. 2003;21:407–13. doi: 10.1183/09031936.03.00010403

Belperio JA, Shaikh F, Abtin F, et al. Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement. EClinicalMedicine. 2021;37:100966. doi: 10.1016/j.eclinm.2021.100966.

Downloads

Published

26-03-2024

Issue

Section

Letter to Editor

How to Cite

1.
Maki Y, Miyata J, Suematsu R, Sasaki H, Kimizuka Y, Fujikura Y, et al. Principal component analysis of clinical characteristics of pulmonary sarcoidosis with or without extrapulmonary lesions: a single-center observational study in Japan. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2024 Mar. 26 [cited 2025 Apr. 10];41(1):e2024022. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/13328